84
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study

, , , , , , & show all
Pages 317-323 | Published online: 18 Apr 2011

References

  • WoodheadMCommunity-acquired pneumonia in Europe: causative pathogens and resistance patternsEur Respir J Suppl20023620s27s12168744
  • American Thoracic Society, European Respiratory SocietyStandards for the Diagnosis and Management of Patients with COPD http://www.thoracic.org/clinical/copd-guidelines/resources/copddoc.pdf. Accessed January 13, 2011.
  • ScheldWMMaintaining fluoroquinolones class effectiveness: review of influencing factorsEmerg Infect Dis200391912533274
  • LonksJRGarauJMedeirosAAImplications of antimicrobial resistance in the empirical treatment of community-acquired respiratory tract infections: the case of macrolidesJ Antimicrob Chemother200250Suppl S2879212556438
  • BlondeauJMA review of the comparative in vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolonesJ Antimicrob Chemother199943Suppl B11110382869
  • WoodheadMBlasiFEwigSGuidelines for the management of adult lower respiratory tract infectionsEur Respir J2005261138118016319346
  • LiuYDiagnosis and treatment guideline for community-acquired pneumoniaChin J Tuberc Respir Dis200629654
  • YaoWDiagnosis and treatment guideline for chronic obstructive pulmonary diseaseChin J Tuberc Respir Dis20073015
  • LiuLYLandenHTreatment of respiratory tract infections with moxifloxacin: results of postmarketing surveillance in ChinaInt J Clin Pract2007611509151517635617